Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-01-30Clinical Trial Update: Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer [Phase 1, Phase 2]
Clinical trial update on a novel dosing schedule for indibulin in metastatic breast cancer, spanning Phase 1 and Phase 2, sponsored by Alaun…
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer [Phase 4]
This document reports the completion of a prospective, open-label Phase 4 trial evaluating anastrozole in postmenopausal women with hormone-…
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation. [Phase 3]
The ABCSG 8 Phase 3 trial for adjuvant treatment in hormone receptor–positive breast cancer with good to moderate differentiation has comple…
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: Phase 2 Study of ABT-869 in Combination With Paclitaxel Versus Paclitaxel Alone to Treat Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluating ABT-869 (linifanib) with paclitaxel versus paclitaxel alone for metastatic breast cancer has completed.
-
CLINICAL_TRIALS research · 2013-01-29Clinical Trial Update: Whole-body MR in Staging Bone and Soft Tissue Metastases in Breast Cancer Patients(MetaMaRBo)
This document provides an update on a clinical trial evaluating the use of whole-body MRI for staging bone and soft tissue metastases in bre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-28Clinical Trial Update: Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor [Phase 2]
A Phase 2 trial evaluating bevacizumab with allogeneic hematopoietic stem cell transplantation for advanced solid tumors, including breast a…
-
CLINICAL_TRIALS trial_result · 2013-01-28Clinical Trial Update: Chemotherapy Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer [Phase 2]
This clinical trial update notes the completion of a Phase 2 trial evaluating chemotherapy followed by surgery in women with stage II or sta…
-
CLINICAL_TRIALS research · 2013-01-28Clinical Trial Update: Evaluation of Clinical Significance of Circulating Markers in Breast Cancer Patients Undergoing Herceptin Therapy
This clinical trial update examines the clinical significance of circulating biomarkers in breast cancer patients treated with trastuzumab (…
-
FDA label_change · 2013-01-25FDA Approved: VABRINTY — Supplemental Application (URONOVA PHARMACEUTICALS, INC.)
FDA approved a supplemental application for VABRINTY (leuprolide acetate) from Uronova Pharmaceuticals, resulting in labeling changes for th…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer [Phase 2]
Phase 2 trial comparing preoperative regimens of trastuzumab with vinorelbine versus docetaxel/carboplatin/trastuzumab in HER2-positive brea…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Liver Safety Under Upfront Arimidex vs Tamoxifen [Phase 4]
Phase 4 trial comparing upfront anastrozole (Arimidex) to tamoxifen in breast cancer provides results focused on liver safety. The results w…
-
CLINICAL_TRIALS trial_result · 2013-01-25Clinical Trial Update: Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer [NA]
A completed breast cancer trial evaluating adjuvant doxorubicin/cyclophosphamide and paclitaxel with sorafenib, with results posted on 2013-…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer [Phase 2]
A Phase 2 trial evaluating a combination of docetaxel, vinorelbine, and filgrastim in women with stage IV breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluated the combination of trastuzumab and gefitinib in metastatic breast cancer, and the study status is completed.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: FR901228 in Treating Patients With Metastatic Breast Cancer [Phase 2]
Phase 2 trial evaluating FR901228 in metastatic breast cancer (Stage IV), including male and recurrent breast cancer cases, has completed en…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer [Phase 3]
A Phase 3 trial comparing a standard doxorubicin/cyclophosphamide/paclitaxel regimen with or without filgrastim in women with inflammatory o…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: S9927 Radiation Therapy After Surgery, Chemotherapy, and/or Hormone Therapy in Stage II Breast Cancer [Phase 3]
Phase 3 clinical trial update for S9927 evaluating radiation therapy after surgery and systemic therapy in stage II breast cancer. The study…
-
CLINICAL_TRIALS withdrawal · 2013-01-24Clinical Trial Update: S0348 Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Breast Cancer in Remission [Phase 2]
The SWOG S0348 Vaccine Therapy trial for stage IIIB or stage IV breast cancer in remission was withdrawn from Phase 2.
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: S9623, Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer [Phase 3]
The SWOG S9623 Phase 3 trial evaluating combination chemotherapy plus peripheral stem cell transplantation for women with breast cancer has …
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer [Phase 3]
Phase 3 clinical trial evaluating tamoxifen with or without combination chemotherapy in postmenopausal women after breast cancer surgery has…
-
CLINICAL_TRIALS research · 2013-01-24Clinical Trial Update: S0029 Docetaxel in Treating Older Women With Metastatic Breast Cancer [Phase 2]
This ClinicalTrials.gov entry reports the termination of a Phase 2 study evaluating docetaxel in older women with metastatic breast cancer.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer [Phase 2]
A Phase 2 trial evaluating imatinib mesylate in patients with metastatic breast cancer has completed and was updated in ClinicalTrials.gov.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: PS-341 in Treating Women With Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial of PS-341 (bortezomib) in women with metastatic breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Aprepitant in the Prevention of Delayed Emesis Induced by Cyclophosphamide Plus Anthracyclines in Breast Cancer Patients [Phase 3]
Phase 3 trial evaluating emend (aprepitant) to prevent delayed emesis in breast cancer patients receiving cyclophosphamide plus anthracyclin…
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations [Phase 1]
Phase 1 trial results evaluate BAY86-9596 as a PET tracer for diagnostic imaging across cancer and inflammatory conditions. The study report…